+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Autophagy in major human diseases

      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 2 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 29 , 30 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 , 98 , 99 , 2 , 79 , 80 , 100 , 101 , , 102 ,
      The EMBO Journal
      John Wiley and Sons Inc.
      aging, cancer, inflammation, metabolic syndromes, neurodegeneration, Autophagy & Cell Death

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Autophagy is a core molecular pathway for the preservation of cellular and organismal homeostasis. Pharmacological and genetic interventions impairing autophagy responses promote or aggravate disease in a plethora of experimental models. Consistently, mutations in autophagy‐related processes cause severe human pathologies. Here, we review and discuss preclinical data linking autophagy dysfunction to the pathogenesis of major human disorders including cancer as well as cardiovascular, neurodegenerative, metabolic, pulmonary, renal, infectious, musculoskeletal, and ocular disorders.


          This review provides an exhaustive overview of the contribution of autophagy to multiple pathological phenotypes in vivo, and discusses the therapeutic potential of autophagy modulation in disease prevention and treatment.

          Related collections

          Most cited references793

          • Record: found
          • Abstract: found
          • Article: found

          The Hallmarks of Aging

          Aging is characterized by a progressive loss of physiological integrity, leading to impaired function and increased vulnerability to death. This deterioration is the primary risk factor for major human pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. Aging research has experienced an unprecedented advance over recent years, particularly with the discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and biochemical processes conserved in evolution. This Review enumerates nine tentative hallmarks that represent common denominators of aging in different organisms, with special emphasis on mammalian aging. These hallmarks are: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. A major challenge is to dissect the interconnectedness between the candidate hallmarks and their relative contributions to aging, with the final goal of identifying pharmaceutical targets to improve human health during aging, with minimal side effects. Copyright © 2013 Elsevier Inc. All rights reserved.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

            Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.
              • Record: found
              • Abstract: found
              • Article: not found

              NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease

              The inflammatory nature of atherosclerosis is well established but the agent(s) that incite inflammation in the artery wall remain largely unknown. Germ-free animals are susceptible to atherosclerosis, suggesting that endogenous substances initiate the inflammation1. Mature atherosclerotic lesions contain macroscopic deposits of cholesterol crystals in the necrotic core but their appearance late in atherogenesis had been thought to disqualify them as primary inflammatory stimuli. However, using a novel microscopic technique, we revealed that minute cholesterol crystals are present in early diet-induced atherosclerotic lesions and that their appearance coincides with the first appearance of inflammatory cells. Other crystalline substances can induce inflammation by stimulating the caspase-1-activating NLRP3 inflammasome2,3, which results in cleavage and secretion of IL-1 family cytokines. Here, we demonstrate that cholesterol crystals also activate the NLRP3 inflammasome in phagocytes in vitro in a process that involves phago-lysosomal damage. Similarly, when injected intraperitoneally, cholesterol crystals induce acute inflammation, which is impaired in mice deficient in components of the NLRP3 inflammasome, cathepsin B, cathepsin L, or IL-1 molecules. Moreover, when low-density lipoprotein receptor (LDLR) deficient mice were reconstituted with NLRP3-, ASC-, or IL-1α/β-deficient bone marrow and fed a high cholesterol diet, they had markedly reduced early atherosclerosis and inflammasome-dependent IL-18 levels. Our results demonstrate that crystalline cholesterol acts as an endogenous danger signal and its deposition in arteries or elsewhere is an early cause rather than a late consequence of inflammation. These findings provide new insights into the pathogenesis of atherosclerosis and point to new potential molecular targets for the therapy of this disease. Cholesterol, an indispensable lipid in vertebrates, is effectively insoluble in aqueous environments and elaborate molecular mechanisms have evolved that regulate cholesterol synthesis and its transport in fluids4. Cholesterol crystals are recognized as a hallmark of atherosclerotic lesions5 and their appearance helps in the histopathological classification of advanced atherosclerotic lesions6. However, crystalline cholesterol is soluble in the organic solvents used in histology, so that the presence of large crystals is identifiable but only indirectly as so-called cholesterol crystal clefts, which delineate the space that was occupied before sample preparation. The large cholesterol crystal clefts in atherosclerotic plaques were typically only observed in advanced lesions and, therefore, crystal deposition was thought to arise late in this disease. However, given that atherosclerosis is intimately linked to cholesterol levels, we were interested to determine when and where cholesterol crystals first appear during atherogenesis. We fed atherosclerosis-prone Apo-E-deficient mice a high cholesterol diet to induce atherosclerosis7,8 and used a combination of laser reflection and fluorescence confocal microscopy3 to identify crystalline materials and immune cells. Many small crystals appeared as early as two weeks after the start of atherogenic diet within small accumulations of subendothelial immune cells in very early atherosclerotic sinus lesions (Fig. 1a, b and Supplementary Fig. 1, 2). The reflective material was identified as being mostly cholesterol crystals by fillipin staining (not shown). Crystal deposition and immune cell recruitment increased steadily with diet feeding and the appearance of crystals correlated with that of macrophages (r2=0.99, p<0.001) (Fig. 1a-d). Cholesterol crystals were not only detected in necrotic cores but also in subendothelial areas that were rich in immune cells. Confocal imaging revealed crystals to localize both inside and outside of cells (Fig. 1b), whereas in corresponding H&E stained sections that were treated with organic solvents during the staining process cholesterol crystal clefts were visible only after 8 weeks of diet and smaller crystals remained invisible (Fig. 1a). As expected, we failed to detect macrophages or accumulation of crystals in the aortic sinus sections in mice on a regular chow diet (Fig. 1a, b; bottom panel). Additional observations in human advanced atherosclerotic lesions showed that areas rich in immune cells also contained smaller crystals inside and outside of cells in addition to the larger crystals that would leave cholesterol crystal clefts in standard histology (Supplementary Fig. 3, 4). These studies establish that crystals emerge at the earliest time points of diet-induced atherogenesis together with the appearance of immune cells in the subendothelial space. Various crystals that are linked to tissue inflammation, as well as pore-forming toxins or extracellular ATP, can activate IL-1 family cytokines via triggering of NLRP39. Of note, NLRP3 inflammasome formation requires a priming step that can be provided by pattern recognition or cytokine receptors that activate NF-κB. Cellular priming leads to induction of pro-forms of IL-1 family cytokines and NLRP3 itself, a step, which is required for NRLP3 activation at least in vitro 10. To test whether cholesterol crystals could activate the release of IL-1β, we incubated LPS-primed human PBMCs with cholesterol crystals. Cholesterol crystals induced a robust, dose-responsive release of cleaved IL-1β in a caspase-1 dependent manner (Fig. 2a, b). Of note, cholesterol crystals added to unprimed cells did not release IL-1β into the supernatant indicating the absence of any contaminants that would be sufficient for priming of cells (Fig. 2a)10. IL-1 cytokines are processed by caspase-1, which can be activated by various inflammasomes9. Since the NLRP3 inflammasome has been reported to recognize a variety of crystals, we next stimulated macrophages from mice deficient in NLRP3 inflammasome components. Cholesterol crystals induced caspase-1 cleavage and IL-1β release in wild-type but not NLRP3- or ASC-deficient macrophages (Fig. 2c, d). Transfected dsDNA (dAdT), a control activator that induces the AIM-2 inflammasome11, activated caspase-1 and induced IL-1β release in an ASC-dependent yet NLRP3-independent manner, as expected (Fig. 2c, d). In addition, mouse macrophages also produced cleaved IL-18, another IL-1 family member that is processed by inflammasomes (Fig. 2e). We also found that chemically pure synthetic cholesterol crystals activated the NLRP3 inflammasome providing further evidence that cholesterol crystals themselves rather than contaminating molecules were the biologically active material (Supplementary Fig. 5a). Notably, priming of cells for NLRP3 activation could be achieved by other pro-inflammatory substances such as cell wall components of Gram-positive bacteria (Supplementary Fig. 5b). Moreover, minimally modified LDL also primes cells for NLRP3 activation (Supplementary Fig. 5c)12. Together, these data establish that crystalline cholesterol leads to NLRP3 inflammasome activation in human and mouse immune cells. Several hypotheses regarding the molecular mechanisms of NLRP3 inflammasome activation have been formulated3,13. To further elucidate the mechanisms involved in cholesterol crystal recognition, we pharmacologically inhibited phagocytosis with cytochalasin D or lantriculin A and found that these agents inhibited NLRP3 inflammasome activation by crystals (Fig. 3 and Supplementary Fig. 6 a, c, d). In contrast, these inhibitors did not block the activation of the NLRP3 inflammasome by the pore-forming toxin nigericin or the AIM2 activator dAdT (Fig. 3a and Supplementary Fig. 6a, c, d). To follow the fate of the internalized particles, we performed combined confocal reflection and fluorescence microscopy in macrophages incubated with cholesterol crystals. This analysis revealed that cholesterol crystals induced profound swelling in a fraction of cells (Fig. 3b) as observed for other aggregated materials3,14. Phago-lysosomal membranes contain lipid raft components15, which allowed us to stain the surface of cells with the raft marker choleratoxin B labeled with one fluorescent color and additionally label internal phago-lysosomal membranes after cell permeabilization with differently fluorescing choleratoxin B. Indeed, in macrophages that had previously ingested cholesterol crystals this staining revealed that some cholesterol crystals lacked phago-lysosomal membranes and resided in the cytosol of a fraction of cells, thus indirectly indicating crystal-induced phago-lysosomal membrane rupture (Fig. 3c). This finding was further supported by crystal-induced translocation of soluble lysosomal markers into the cytosol (see below). Additionally, in mouse macrophages cholesterol crystals dose-responsively led to a loss of lysosomal acridine orange fluorescence further confirming lysosomal disruption (Fig. 3d). These studies suggest that cholesterol crystals induced lysosomal damage in macrophages leads to the translocation of phago-lysosomal content into the cytosol. In further experiments we found that the inhibition of lysosomal acidification or cathepsin activity blocked the ability of cholesterol crystals to induce IL-1β secretion (Fig. 3e). Likewise, analysis of cells from mice deficient in single cathepsins (B or L) also showed that cholesterol crystals led to a diminished IL-1β release when compared to wild-type cells. However, the dependency of cholesterol crystal-induced IL-1β release on single cathepsins was less pronounced at higher doses suggesting functional redundancy of cathepsin B and L or potentially additional proteases (Fig. 3f). Together, these experiments suggest that cholesterol crystals induce translocation of lysosomal proteolytic contents, which can be sensed by the NLRP3 inflammasome by as yet undefined mechanisms. It has previously been demonstrated that oxidized LDL, a major lipid species deposited in vessels, has the potential to damage lysosomal membranes16. We found that macrophages incubated with oxidized LDL internalized this material and nucleated crystals in large, swollen, phago-lysosomal compartments (Fig. 3g); and in some cells these compartments ruptured with translocation of the fluorescent marker dye into the cytosol (Fig. 3g, arrows). A time course analysis revealed that small crystals appeared as early as one hour after incubation with oxidized LDL (not shown) and larger crystals were visible after longer incubation times (Fig. 3h). It is likely that cholesterol crystals form due to the activity of acid cholesterol ester hydolases, which transform cholesteryl esters supplied by oxidized LDL into free cholesterol. As indicated above, minimally modified LDL can prime cells for the NLRP3 inflammasome activation (Supplementary Fig. 5c). Recent evidence suggests that this priming proceeds via the activation of a TLR4/6 homodimer and CD3612. This, together with the propensity of minimally modified LDL to form crystals and to rupture lysosomal membranes, suggests that these LDL species could be sufficient to provide both signals 1 and 2 needed to activate IL-1β release from cells. Indeed, after 24 h incubation we observed spontaneous release of IL-1β in the absence of further NLRP3 inflammasome stimulation (Fig. 3i). In murine atherosclerotic lesions we identified not only macrophages and dendritic cells but also neutrophils accumulated within the intima space (see Supplementary Fig. 2). IL-1β plays a key role in the recruitment of neutrophils, and the IL-1-dependent intraperitoneal accumulation of neutrophils has frequently been used as an in vivo assay for inflammasome activation and IL-1 production2,17,18. Using this acute inflammation model we found that cholesterol crystals induced a robust induction of neutrophil influx into the peritoneum (Fig. 4a). Neutrophil influx into the peritoneum after cholesterol crystal deposition was markedly reduced in mice lacking IL-1 or the IL-1 receptor (IL-1R), indicating that IL-1 production is indeed induced and essential for cholesterol crystal-induced inflammation in vivo. Moreover, mice lacking NLRP3 inflammasome components or cathepsins B or L also recruited significantly fewer neutrophils into the peritoneum after cholesterol crystal injection than wild-type mice. However, the reduction in neutrophilic influx observed after cholesterol crystal deposition was more pronounced in mice lacking IL-1 related genes than in mice lacking NLRP3 inflammasome related genes (Fig. 4a), presumably because of the contribution of IL-1α signaling and/or caspase-1-independent processing of IL-1β19 in vivo. In any case, these data confirm that cholesterol crystals trigger NLRP3 inflammasome-dependent IL-1 production in vivo. To test whether the NLRP3 inflammasome is involved in the chronic inflammation that underlies atherogenesis in vessel walls, we tested whether the absence of NLRP3, ASC or IL-1 cytokines might modulate atherosclerosis development in LDLR-deficient mice20, a model for familial hypercholesterolemia. We reconstituted lethally irradiated LDLR-deficient mice with bone marrow from wild-type or NLRP3-,ASC- or IL1α/β-deficient mice and subjected these mice to 8 weeks of a high cholesterol diet. In these radiation bone marrow chimeras, the LDLR-deficiency radioresistant parenchyma causes the animals to become hypercholesterolemic when placed on a high fat diet, while their bone-marrow derived macrophages and other leukocytes lack the NLRP3-inflammasome or IL-1 pathway components needed to respond to cholesterol crystals. We found that the different groups of mice had similar levels of elevated blood cholesterol (not shown). However, mice reconstituted with NLRP3-, ASC-, or IL-1α/b-deficient bone marrow showed significantly lower plasma IL-18 levels, an IL-1 family cytokine whose secretion is dependent on inflammasomes and a biomarker known to be elevated in atherosclerosis21 (Fig. 4b). Additionally, and most importantly, mice whose bone marrow-derived cells lacked NLRP3 inflammasome components or IL-1 cytokines were markedly resistant to developing atherosclerosis (Fig. 4c, d). The lesional area in the aortas of these mice was reduced on average by 69% compared to chimeric LDLR-deficient mice that had wild-type bone marrow. These data demonstrate that activation of the NLRP3 inflammasome by bone marrow derived cells is a major contributor to diet-induced atherosclerosis in mice. The molecules that incite inflammation in atherosclerotic lesions have presented a long-standing puzzle. While the lesions are absolutely dependent on cholesterol, this abundant, naturally occurring molecule has been viewed as inert. Here, we show that the crystalline form of cholesterol can induce inflammation. The magnitude of the inflammatory response and the mechanism of NRLP3 activation appear identical to that of crystalline uric acid, silica and asbestos2,3,13. All these crystals are known to provoke clinically important inflammation as seen in gout, silicosis and asbestosis, respectively. The chronic inflammation in gout, silicosis and asbestosis is thought to derive from the inability of cells to destroy the ingested aggregates leading to successive rounds of apoptosis and reingestion of the crystalline material22. In the same way, immune cells cannot degrade cholesterol and depend, instead, on exporting the cholesterol to HDL particles, which carry the cholesterol to the liver for disposal. The success of this or any cellular mechanism in clearing crystals may thus depend on the availability of HDL. Low blood HDL levels are among the most prominent risk factors for atherosclerotic disease23, and pharmacologic means for increasing HDL are being actively pursued as treatments. Even though cholesterol cannot be degraded by peripheral cells it may be transformed to cholesteryl ester by the cellular enzyme, acylcoenzyme A:cholesterol acyltransferase (ACAT). Cholesteryl esters form droplets rather than crystals and are considered a storage form of cholesterol4. On the assumption that reduced cholesterol storage would be beneficial for reducing atherosclerosis, ACAT inhibitors were tested in large clinical trials. Studies with two such inhibitors showed not a decrease but an increase in the size of the coronary atheroma24,25. This apparent paradox may be reconciled by our findings that the crystalline form of cholesterol, which would be expected to be increased after inhibition of ACAT, may be key in driving arterial inflammation. Indeed, murine studies of ACAT-deficiency show enhanced atherogenesis with abundant cholesterol crystals26. Based on our findings, therapeutic strategies that would reduce cholesterol crystals or block the inflammasome pathway would be predicted to have clinical benefit by reducing the initiation or progression of atherosclerosis. In this context our findings also point to novel molecular targets for the development of therapeutics to treat this disease. Methods summary Mice Mice were kindly provided as follows: NLRP3−/− and ASC−/− (Millenium Pharmaceuticals); Caspase-1−/− (R. Flavell, Yale University, New Haven, CT). Cathepsin B−/− (T. Reinheckel, Albert-Ludwigs-University, Freiburg, Germany), Cathepsin L−/− (H. Ploegh, Whitehead Institute, Cambridge, MA), IL-1α−/− IL-1β−/−, IL-1α−/−β−/− (Yoichiro Iwakura, The Institute of Medical Sciences, The University of Tokyo, Tokyo, Japan). B6-129 (mixed background), C57BL/6, IL-1R−/−, ApoE−/− and LDLR−/− mice were purchased from The Jackson Laboratories. Animal experiments were approved by the UMass and Massachusetts General Hospital Animal Care and Use Committees. Cell culture media and reagents Immortalized macrophage cell lines and bone-marrow derived cells were cultured as described3 and primed with 10 ng/ml LPS for 2h prior to addition of inflammasome stimuli. Inhibitors were added 30 min prior to stimuli. Crystals and dAdT were applied 6h, ATP (5 mM) and nigericin (10 µM) 1h before supernatant was collected. Poly(dA:dT) was transfected using Lipofectamine 2000 (Invitrogen). Human PBMCs were freshly isolated by Ficoll-Hypaque gradient centrifugation, grown in RPMI medium (Invitrogen), 10% FBS (Atlas Biologicals) 10µg/ml ciprofloxacin (Celgro) at 2 × 105 cells per 96 well and primed with 50 pg/ml LPS for 2 hours before addition of inflammasome stimuli. Supernatants were assessed for IL-1β by ELISA and western blot. Neutrophil recruitment to peritoneal cavity Mice were intraperitoneally injected with 2 mg of cholesterol crystals in 200 µl PBS or PBS alone. After 15 hours, peritoneal lavage cells were stained with fluorescently conjugated mAbs against Ly-6G (Becton Dickinson, clone 1A8) and 7/4 (Serotec) in the presence of mAb 2.4G2 (FcgRIIB/III receptor blocker). The absolute number of neutrophil (Ly-6G+ 7/4+) was determined by flow cytometry. Methods Reagents Bafilomycin A1, cytochalasin D and zYVAD-fmk were from Calbiochem. ATP, acridine orange and poly(dA:dT) sodium salt were form Sigma-Aldrich and ultra-pure LPS was purchased from Invivogen. Nigericin, Hoechst dye, DQ ovalbumin and fluorescent choleratoxin B were purchased from Invitrogen. MSU crystals were prepared as described17. Cholesterol crystal preparation Tissue-culture grade or synthetic cholesterol was purchased from Sigma, solubilized in hot acetone and crystallized by cooling. After 6 cycles of recrystallizations, the final crystallization was performed in the presence of 10% endotoxin-free water to obtain hydrated cholesterol crystals. Cholesterol crystals were analyzed for purity by electron impact GC/MS and thin layer chromatography using silica gel and hexane-ethyl acetate (80:20) solvent. Crystal size was varied using a microtube tissue grinder. Fluorescent cholesterol was prepared by addition of the DiD or DiI dyes (Invitrogen) in PBS. ELISA and Western Blot ELISA measurements of IL-1β (Becton Dickinson) and IL-18 (MBL International) were made according to the manufacturer’s directions. Experiments for caspase-1 Western blot analysis were performed in serum-free DMEM medium. After stimulations, cells were lysed by the addition of a 10X lysis buffer (10% NP-40 in TBS and protease inhibitors), and post-nuclear lysates were separated on 4–20% reducing SDS-PAGE. Anti murine caspase-1 pAb was kindly provided by P. Vandenabeele (University of Ghent, The Netherlands). Anti-human cleaved IL-1β (Cell Signaling) from human PBMCs was analyzed in serum-free supernatants as above without cell lysis. Confocal microscopy ApoE−/− mice that were maintained in a pathogen-free facility were fed a Western-type diet (Teklad Adjusted Calories 88137; 21% fat (wt/wt), 0.15% cholesterol (wt/wt) and 19.5% casein (wt/wt); no sodium cholate) starting at 8 weeks of age and continued for 2, 4, 8 or 12 weeks (three mice in each group). Mice were euthanized and hearts were collected as described27. Hearts were serially sectioned at the origins of the aortic valve leaflets, and every third section (5 µm) was stained with hematoxylin and eosin and imaged by light microscopy. Adjacent sections were fixed in 4% paraformaldehyde, blocked and permeabilized (10% goat serum / 0.5% saponin in PBS) and stained with fluorescent primary antibodies against macrophages (MoMa-2, Serotec), DCs (CD11c, Becton Dickinson) or neutrophils (anti-Neutrophil, Serotec) for 1 h at 37 °C for imaging by confocal microscopy. Human atherosclerotic lesions were obtained directly after autopsy, serially sectioned at 2- to 3-mm intervals and frozen sections (5 mm) were prepared as above. Parallel sections were stained with Masson’s trichrome stain. Tissues were prepared for microscopy as above. Macrophages were stained with anti-CD68 (Serotec), smooth muscle cells were visualized with fluorescent phalloidin (Invitrogen). Human and mouse samples were counterstained with Hoechst dye to visualize nuclei. The atherosclerotic lesions were imaged on a Leica SP2 AOBS confocal microscope where immunofluoroscence staining was visualized by standard confocal techniques and crystals were visualized utilizing laser reflection using enhanced transmittance of the acousto-optical beam splitter as described3. Of note, laser reflection and fluorescence emission occurs at the same confocal plane in this setup. The mean lesion area, amount of crystal deposition and monocyte marker presence was quantified from three digitally captured sections per mouse (Photoshop CS4 Extended). For the quantification of crystal mass and macrophages present, the sum of positive pixels (laser reflection or fluorescence, respectively) was determined and the area calculated from the pixel size. Confocal microscopy of mouse macrophages was performed as described3. DQ ovalbumin only fluoresces upon proteolytic processing and marks phagolysosomal compartments in macrophages. Acridine orange lysosomal damage assay This assay was performed by flow cytometry as described3. Bone marrow transplantation and atherosclerosis model Eight weeks-old female LDLR−/− mice were lethally irradiated (11 Gy). Bone marrow was prepared from femurs and tibias of C57BL/6, NLRP3−/−, ASC−/− and IL-1α−/−b−/− donor mice and T cells were depleted using complement (Pel-Freez Biologicals) and anti-Thy1 mAB (M5/49.4.1, ATCC). Irradiated recipient mice were reconstituted with 3.5 × 106 bone marrow cells administered into the tail vein. After 4 weeks, mice were fed with a Western-type diet (Teklad Adjusted Calories 88137; 21% fat [wt/wt], 0.15% cholesterol [wt/wt] and 19.5% casein [wt/wt]; no sodium cholate) for 8 weeks. Mice were euthanized and intracardially perfused with formalin. Hearts were embedded in OTC (Richard-Allen Scientific, Kalamazoo, MI) medium, frozen, and serially sectioned through the aorta from the origins of the aortic valve leaflets and every single section (10 µm) throughout the aortic sinus (800 µm) was collected. Quantification of average lesion area was done from 12 stained with hematoxylin eosin or Giemsa per mouse by two independent investigators with virtually identical results. Serum cholesterol levels were determined by enzymatic assay (Wako Diagnostics), and serum IL-18 was measured by SearchLight protein array technology (Aushon Biosystems, Billerica, MA). Statistical analyses The significance of differences between groups was evaluated by one–way analysis of variance (ANOVA) with Dunnett’s post- comparison test for multiple groups to control group, or by Student’s t test for 2 groups. R squared was calculated from the Pearson correlation coefficient. Analyses were done using Prism (GraphPad Software, Inc.). Supplementary Material 1 2 3

                Author and article information

                EMBO J
                EMBO J
                The EMBO Journal
                John Wiley and Sons Inc. (Hoboken )
                30 August 2021
                01 October 2021
                30 August 2021
                : 40
                : 19 ( doiID: 10.1002/embj.v40.19 )
                : e108863
                [ 1 ] Life Sciences Institute University of Michigan Ann Arbor MI USA
                [ 2 ] Department of Radiation Oncology Weill Cornell Medical College New York NY USA
                [ 3 ] Department of Medicine University of Pennsylvania Philadelphia PA USA
                [ 4 ] Abramson Cancer Center University of Pennsylvania Philadelphia PA USA
                [ 5 ] Department of Molecular, Cell and Cancer Biology University of Massachusetts Medical School Worcester MA USA
                [ 6 ] Telethon Institute of Genetics and Medicine Pozzuoli Italy
                [ 7 ] Department of Translational Medical Sciences Section of Pediatrics Federico II University Naples Italy
                [ 8 ] Department of Molecular and Human Genetics Baylor College of Medicine, and Jan and Dan Duncan Neurological Research Institute Texas Children Hospital Houston TX USA
                [ 9 ] Margarita Salas Center for Biological Research Spanish National Research Council Madrid Spain
                [ 10 ] Faculty of Medicine Department Section of Physiology Complutense University of Madrid Madrid Spain
                [ 11 ] Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) Madrid Spain
                [ 12 ] Kimmel Center for Biology and Medicine at the Skirball Institute New York University Grossman School of Medicine New York NY USA
                [ 13 ] Department of Microbiology New York University Grossman School of Medicine New York NY USA
                [ 14 ] Division of Gastroenterology and Hepatology Department of Medicine New York University Langone Health New York NY USA
                [ 15 ] Cell Stress and Survival Unit Center for Autophagy, Recycling and Disease (CARD) Danish Cancer Society Research Center Copenhagen Denmark
                [ 16 ] Department of Pediatric Onco‐Hematology and Cell and Gene Therapy IRCCS Bambino Gesù Children's Hospital Rome Italy
                [ 17 ] Department of Biology University of Rome ‘Tor Vergata’ Rome Italy
                [ 18 ] Division of Pulmonary and Critical Care Medicine Joan and Sanford I. Weill Department of Medicine Weill Cornell Medicine New York NY USA
                [ 19 ] New York‐Presbyterian Hospital Weill Cornell Medicine New York NY USA
                [ 20 ] Division of Nephrology and Hypertension Joan and Sanford I. Weill Department of Medicine Weill Cornell Medicine New York NY USA
                [ 21 ] Department of Pathology University of Pittsburgh School of Medicine Pittsburgh PA USA
                [ 22 ] Institut Necker‐Enfants Malades INSERM U1151‐CNRS UMR 8253 Paris France
                [ 23 ] Université de Paris Paris France
                [ 24 ] Laboratorio de Mecanismos Moleculares Implicados en el Tráfico Vesicular y la Autofagia‐Instituto de Histología y Embriología (IHEM)‐Universidad Nacional de Cuyo CONICET‐ Facultad de Ciencias Médicas Mendoza Argentina
                [ 25 ] Department of Developmental and Molecular Biology Albert Einstein College of Medicine Bronx NY USA
                [ 26 ] Institute for Aging Studies Albert Einstein College of Medicine Bronx NY USA
                [ 27 ] Autophagy Inflammation and Metabolism (AIM Center of Biomedical Research Excellence University of New Mexico Health Sciences Center Albuquerque NM USA
                [ 28 ] Department of Molecular Genetics and Microbiology University of New Mexico Health Sciences Center Albuquerque NM USA
                [ 29 ] Institute of Biochemistry II School of Medicine Goethe University Frankfurt, Frankfurt am Main Germany
                [ 30 ] Buchmann Institute for Molecular Life Sciences Goethe University Frankfurt, Frankfurt am Main Germany
                [ 31 ] Department of Biomolecular Sciences The Weizmann Institute of Science Rehovot Israel
                [ 32 ] Institute of Biomedicine University of Turku Turku Finland
                [ 33 ] Department of Molecular Medicine Sapienza University of Rome Rome Italy
                [ 34 ] Department of Epidemiology Preclinical Research, and Advanced Diagnostics National Institute for Infectious Diseases ‘L. Spallanzani’ IRCCS Rome Italy
                [ 35 ] Department of Pharmacology and Toxicology School of Medicine Virginia Commonwealth University Richmond VA USA
                [ 36 ] Department of Immunology St. Jude Children's Research Hospital Memphis TN USA
                [ 37 ] Sanford Burnham Prebys Medical Discovery Institute Program of Development Aging, and Regeneration La Jolla CA USA
                [ 38 ] Cell Death and Metabolism Center for Autophagy, Recycling & Disease Danish Cancer Society Research Center Copenhagen Denmark
                [ 39 ] Department of Cellular and Molecular Medicine Faculty of Health Sciences University of Copenhagen Copenhagen Denmark
                [ 40 ] Department of Medical Biology Molecular Cancer Research Group University of Tromsø—The Arctic University of Norway Tromsø Norway
                [ 41 ] Institute of Genetics Biological Research Center Szeged Hungary
                [ 42 ] Department of Anatomy, Cell and Developmental Biology Eötvös Loránd University Budapest Hungary
                [ 43 ] Merck & Co., Inc. Kenilworth NJ USA
                [ 44 ] Institute of Biochemistry and Molecular Biology ZBMZ Faculty of Medicine University of Freiburg Freiburg Germany
                [ 45 ] CIBSS ‐ Centre for Integrative Biological Signalling Studies University of Freiburg Freiburg Germany
                [ 46 ] Centre de Recherche des Cordeliers Equipe Labellisée par la Ligue Contre le Cancer Université de Paris Sorbonne Université Inserm U1138 Institut Universitaire de France Paris France
                [ 47 ] Metabolomics and Cell Biology Platforms Institut Gustave Roussy Villejuif France
                [ 48 ] Pôle de Biologie Hôpital Européen Georges Pompidou AP‐HP Paris France
                [ 49 ] Suzhou Institute for Systems Medicine Chinese Academy of Medical Sciences Suzhou China
                [ 50 ] Karolinska Institute Department of Women's and Children's Health Karolinska University Hospital Stockholm Sweden
                [ 51 ] Signalling Programme Babraham Institute Cambridge UK
                [ 52 ] Centre for Cancer Biology University of South Australia Adelaide SA Australia
                [ 53 ] Faculty of Health and Medical Sciences University of Adelaide Adelaide SA Australia
                [ 54 ] Departamento de Bioquímica y Biología Molecular Facultad de Medicina Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo Oviedo Spain
                [ 55 ] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain
                [ 56 ] The Ben May Department for Cancer Research The Gordon Center for Integrative Sciences W‐338 The University of Chicago Chicago IL USA
                [ 57 ] The University of Chicago Chicago IL USA
                [ 58 ] Institute of Molecular Biosciences NAWI Graz University of Graz Graz Austria
                [ 59 ] BioTechMed‐Graz Graz Austria
                [ 60 ] Field of Excellence BioHealth – University of Graz Graz Austria
                [ 61 ] Immunity, Inflammation and Disease Laboratory National Institute of Environmental Health Sciences NIH Research Triangle Park NC USA
                [ 62 ] Biology Department, Queens College City University of New York Flushing NY USA
                [ 63 ] The Graduate Center Biology and Biochemistry PhD Programs of the City University of New York New York NY USA
                [ 64 ] Department of Biochemistry and Molecular Biology Graduate School of Medicine The University of Tokyo Tokyo Japan
                [ 65 ] Viral Immunobiology Institute of Experimental Immunology University of Zurich Zurich Switzerland
                [ 66 ] Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) Vienna BioCenter (VBC) Vienna Austria
                [ 67 ] Department of Medical Genetics Life Sciences Institute University of British Columbia Vancouver BC Canada
                [ 68 ] Department of Anatomy University of California, San Francisco San Francisco CA USA
                [ 69 ] Department of Pathology University of California, San Francisco San Francisco CA USA
                [ 70 ] Helen Diller Family Comprehensive Cancer Center University of California, San Francisco San Francisco CA USA
                [ 71 ] Department of Biology University of Rome “Tor Vergata” Rome Italy
                [ 72 ] Laboratory of Molecular Medicine Institute of Cytology Russian Academy of Science Saint Petersburg Russia
                [ 73 ] Department of Biomedical Sciences of Cells & Systems Molecular Cell Biology Section University of Groningen University Medical Center Groningen Groningen The Netherlands
                [ 74 ] Department of Medical Genetics Cambridge Institute for Medical Research University of Cambridge Cambridge UK
                [ 75 ] UK Dementia Research Institute University of Cambridge Cambridge UK
                [ 76 ] Cancer Research UK Beatson Institute Glasgow UK
                [ 77 ] Institute of Cancer Sciences University of Glasgow Glasgow UK
                [ 78 ] Department of Cell Biology and Molecular Medicine Cardiovascular Research Institute Rutgers New Jersey Medical School Newark NJ USA
                [ 79 ] Sandra and Edward Meyer Cancer Center New York NY USA
                [ 80 ] Caryl and Israel Englander Institute for Precision Medicine New York NY USA
                [ 81 ] Istituto Veneto di Medicina Molecolare Padova Italy
                [ 82 ] Department of Biology University of Padova Padova Italy
                [ 83 ] Institute of Pharmacology University of Bern Bern Switzerland
                [ 84 ] Department of Clinical Immunology and Allergology Sechenov University Moscow Russia
                [ 85 ] Laboratory of Molecular Immunology Institute of Fundamental Medicine and Biology Kazan Federal University Kazan Russia
                [ 86 ] The Kennedy Institute of Rheumatology NDORMS University of Oxford Oxford UK
                [ 87 ] Department of Molecular Medicine Institute of Basic Medical Sciences University of Oslo Oslo Norway
                [ 88 ] Centre for Cancer Cell Reprogramming Institute of Clinical Medicine University of Oslo Oslo Norway
                [ 89 ] Department of Molecular Cell Biology Institute for Cancer Research Oslo University Hospital Montebello Oslo Norway
                [ 90 ] Institute of Molecular Biology and Biotechnology Foundation for Research and Technology‐Hellas Heraklion, Crete Greece
                [ 91 ] Department of Basic Sciences School of Medicine University of Crete Heraklion, Crete Greece
                [ 92 ] Molecular Cell Biology of Autophagy The Francis Crick Institute London UK
                [ 93 ] Department of Genetics Graduate School of Medicine Osaka University Suita Japan
                [ 94 ] Department of Intracellular Membrane Dynamics Graduate School of Frontier Biosciences Osaka University Suita Japan
                [ 95 ] Integrated Frontier Research for Medical Science Division Institute for Open and Transdisciplinary Research Initiatives (OTRI) Osaka University Suita Japan
                [ 96 ] Interdisciplinary Research Center on Biology and Chemistry Shanghai Institute of Organic Chemistry Chinese Academy of Sciences Shanghai China
                [ 97 ] Department of Cell Biology Harvard Medical School Boston MA USA
                [ 98 ] Department of Neurology Friedman Brain Institute Icahn School of Medicine at Mount Sinai New York NY USA
                [ 99 ] Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education Department of Pathophysiology Shanghai Jiao Tong University School of Medicine (SJTU‐SM) Shanghai China
                [ 100 ] Department of Dermatology Yale School of Medicine New Haven CT USA
                [ 101 ] Université de Paris Paris France
                [ 102 ] Department of Biosciences and Nutrition Karolinska Institute Huddinge Sweden
                Author notes
                [*] [* ] Corresponding author. Tel: +1 646 962 2095; E‐mail: deadoc80@ 123456gmail.com

                Corresponding author. Tel: +46 0 720327239; E‐mail: federico.pietrocola@ 123456ki.se

                Author information
                © 2021 The Authors. Published under the terms of the CC BY 4.0 license

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                : 07 July 2021
                : 01 June 2021
                : 12 July 2021
                Page count
                Figures: 4, Tables: 11, Pages: 63, Words: 63323
                Custom metadata
                01 October 2021
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.8 mode:remove_FC converted:04.10.2021

                Molecular biology
                aging,cancer,inflammation,metabolic syndromes,neurodegeneration,autophagy & cell death


                Comment on this article